Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,661,038
  • Shares Outstanding, K 352,431
  • Annual Sales, $ 8,380 M
  • Annual Income, $ -4,148,000 K
  • 60-Month Beta 0.91
  • Price/Sales 1.25
  • Price/Cash Flow 2.42
  • Price/Book 4.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 1.15
  • Number of Estimates 7
  • High Estimate 1.26
  • Low Estimate 1.06
  • Prior Year 1.05
  • Growth Rate Est. (year over year) +9.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.34 +10.64%
on 01/13/20
30.39 -0.46%
on 01/17/20
+0.75 (+2.54%)
since 12/17/19
3-Month
22.24 +36.02%
on 10/18/19
31.97 -5.38%
on 12/13/19
+7.45 (+32.68%)
since 10/17/19
52-Week
18.72 +61.59%
on 10/07/19
31.97 -5.38%
on 12/13/19
+7.22 (+31.35%)
since 01/17/19

Most Recent Stories

More News
Should Value Investors Pick Bausch Health (BHC) Stock Now?

Is Bausch Health (BHC) a great pick from the value investor's perspective right now? Read on to know more.

BHC : 30.25 (+1.68%)
Aerie's (AERI) Application for Roclanda Accepted in Europe

European authorities accept Aerie's (AERI) filing for its second ophthalmology drug, Roclanda.

AGN : 192.68 (-0.59%)
PFE : 40.51 (-0.25%)
AERI : 22.74 (-5.68%)
BHC : 30.25 (+1.68%)
5 Reasons Why Ironwood Stock Should Be in Your Portfolio

We provide five reasons which makes Ironwood (IRWD) a good investment option in 2020.

AZN : 51.33 (+1.62%)
AGN : 192.68 (-0.59%)
IRWD : 12.60 (-0.87%)
BHC : 30.25 (+1.68%)
Bausch's (BHC) Arazlo Gets FDA Approval for Acne Vulgaris

Bausch (BHC) gets FDA approval for Arazlo Lotion for the topical treatment of acne vulgaris in patients nine years of age or older.

ALKS : 19.24 (-3.75%)
INVA : 14.43 (-0.55%)
ANIK : 45.43 (-3.57%)
BHC : 30.25 (+1.68%)
Top Ranked Value Stocks to Buy for December 13

Top Ranked Value Stocks to Buy for December 13

ODP : 2.59 (+4.86%)
NMM : 16.15 (-1.28%)
BHC : 30.25 (+1.68%)
AEL : 28.95 (+0.03%)
Are You Looking for a Top Momentum Pick? Why Bausch Health (BHC) is a Great Choice

Does Bausch Health (BHC) have what it takes to be a top stock pick for momentum investors? Let's find out.

BHC : 30.25 (+1.68%)
Is Bausch Health (BHC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

BHC : 30.25 (+1.68%)
Why Is Bausch (BHC) Up 8.2% Since Last Earnings Report?

Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BHC : 30.25 (+1.68%)
Why Bausch (BHC) Might be Well Poised for a Surge

Bausch (BHC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

BHC : 30.25 (+1.68%)
Moving Average Crossover Alert: Bausch Health Companies

Bausch Health Companies is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

BHC : 30.25 (+1.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BHC with:

Business Summary

Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals,...

See More

Key Turning Points

2nd Resistance Point 30.76
1st Resistance Point 30.50
Last Price 30.25
1st Support Level 29.88
2nd Support Level 29.52

See More

52-Week High 31.97
Last Price 30.25
Fibonacci 61.8% 26.91
Fibonacci 50% 25.34
Fibonacci 38.2% 23.78
52-Week Low 18.72

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar